Comparison of the IHC, FISH, SISH and qPCR methods for the molecular diagnosis of breast cancer

Molecular Medicine Reports

Volumn 6, Issue 2, 2012, Pages 439-443

  Tvrdík, Daniel ^a   Stanik L ^a   Skalova H ^a   Dundr, P ^a   Velenska Z ^a   Povysil C ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

Author keywords

Breast cancer; Fluorescence in situ hybridization; Her2; Immunohistochemistry; Quantitative polymerase chain reaction; Silver in situ hybridization

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2;

ADULT; ARTICLE; BREAST CARCINOMA; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE AMPLIFICATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MOLECULAR DIAGNOSIS; POLYMERASE CHAIN REACTION; PROTEIN ANALYSIS; PROTEIN EXPRESSION; QUANTITATIVE POLYMERASE CHAIN REACTION; SILVER IN SITU HYBRIDIZATION;

ADULT; AGED; BIOPSY, NEEDLE; BREAST NEOPLASMS; DNA, NEOPLASM; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION, FLUORESCENCE; MIDDLE AGED; POLYMERASE CHAIN REACTION; RECEPTOR, ERBB-2; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

EID: 84863453027     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2012.919     Document Type: Article

References (16)

1. Slamon DJ, Godolphin W, Jones LA, et al: Studies of Her2/neu proto-oncogene in human breast and ovarian cancer. Science 244: 707-712, 1989. (Pubitemid 19147683)
2. Slamon DJ, Clark GM, Wong SG, Levin WJ, Ullrich and McGuire WL: Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene. Science 235: 177-182, 1987. (Pubitemid 17231334)
3. Andrulis IL, Bull SB, Blackstein ME, et al: Neu/erbB-2 amplification identifies a poor-prognosis group of women with node-negative breast cancer. Toronto Breast Cancer Study Group. J Clin Oncol 16: 1340-1349, 1998. (Pubitemid 28175749)
4. Press MF, Bernstein L, Thomas PA, et al: HER-2/neu gene amplification characterized by fluorescence in situ hybridization: poor prognosis in node-negative breast carcinomas. J Clin Oncol 15: 2894-2904, 1997. (Pubitemid 27330017)
5. Ro JS, El-Naggar A, Ro JY, Blick M, Frye D, Fraschini G, Fritsche H and Hortobagyi G: C-erbB-2 amplification in node-negative human breast cancer. Cancer Res 49: 6941-6944, 1989. (Pubitemid 20016571)
6. Paterson MC, Dietrich KD, Danyluk J, et al: Correlation between c-erbB-2 amplification and risk of recurrent disease in node-negative breast cancer. Cancer Res 51: 556-567, 1991.
7. Duffy MJ: Predictive markers in breast and other cancers: a review. Clin Chem 51: 494-503, 2005.
8. Davoli A, Hocevar BA and Brown TL: Progression and treatment of HER2-positive breast cancer. Cancer Chemother Pharmacol 65: 611-623, 2010.
9. Quddus RM, Sung JC, Zhang C, Pasqueriello T, Eklund M and Steinhoff MM: Her2/neu expression in locally advanced breast carcinomas: pre- and post-neoadjuvant chemotherapy. Breast Cancer 12: 294-298, 2005.
10. Jones C, Ford E, Gillett C, et al: Molecular cytogenetic identification of subgroups of grade III invasive ductal breast carcinomas with different clinical outcomes. Clin Cancer Res 10: 5988-5997, 2004. (Pubitemid 39287503)
11. Van de Vijver M: Gene-Expression profiling and the future of adjuvant therapy. Oncologist 10: 30-34, 2005.
12. Hoff ER, Tubb RR, Myles JL and Procop GW: Her2/neu amplification in breast cancer: stratification by tumor type and grade. Am J Clin Pathol 117: 916-921, 2002. (Pubitemid 34564348)
13. Skálová H, Dundr P, Povýšil C, Velenská Z, Petruželka L and Tvrdík D: Study of the effect of neoadjuvant chemotherapy on the status of Her2/neu. Folia Biol (Praha) 57: 191-199, 2011.
14. Biéche I, Onody P, Laurendeau I, Martine O, Vidaud D, Lidereau R and Vidaud M: Real-time reverse transcription-PCR assay for future management of ERBB2-based clinical applications. Clin Chem 45: 1148-1156, 1999. (Pubitemid 29424251)
15. Lyon E, Millson A, Lowery MC, Woods R and Wittwer CT: Quantification of HER2/neu gene amplification by competitive pcr using fluorescent melting curve analysis. Clin Chem 47: 844-851, 2001. (Pubitemid 32398035)
16. Riehle U, Mader A, Brandstetter T, Rühe J, zur Hausen A and Stickeler E: Nucleic acid sequence-based amplification in formalin-fixed and paraffin-embedded breast-cancer tissues. J Clin Pathol 63: 1071-1076, 2010.